tm
Seeing Is Believing
tm
Seeing Is Believing
Currently, out of the existing stock ratings of Graig Suvannavejh - 74 which are a Buy (61.67%), 39 which are a Hold (32.5%), 7 which are a Sell (5.83%)
Analyst Graig Suvannavejh works at MIZUHO and is covering the Healthcare sector with 264 price targets and ratings displayed on 29 stocks. Previously, Graig Suvannavejh worked at GOLDMAN SACHS.
Graig Suvannavejh's average stock forecast success ratio is 56.47% with an average time for price targets to be met of 75.45 days.
Most recent stock forecast was given on AXSM, Axsome Therapeutics at 25-Sep-2023.
Analyst best performing recommendations are on ADVM (ADVERUM BIOTECHNOLOGIES).
The best stock recommendation documented was for INSM (INSMED) at 2/3/2020. The price target of $33 was fulfilled within 1 day with a profit of $4.12 (14.27%) receiving and performance score of 142.66.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Sell
4
$-2.6 (-39.39%)
6
3 days ago
2/4 (50%)
$-0.47 (-18.36%)
163
Buy
10
$3.4 (51.52%)
12
1 months 17 days ago
2/7 (28.57%)
$4.1 (29.04%)
26
Hold
8
$1.4 (21.21%)
18
1 months 20 days ago
0/3 (0%)
$5.88 (24.84%)
Hold
10
$3.4 (51.52%)
10
1 months 21 days ago
1/6 (16.67%)
$8.27 (47.16%)
74
Buy
36
$29.4 (445.45%)
3 years 7 months 1 days ago
1/1 (100%)
$10.1 (39.00%)
495
